Syncope resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 63: | Line 63: | ||
:❑ Standing | :❑ Standing | ||
----- | ----- | ||
'''Inquire about | '''Inquire about medications intake:''' | ||
<table> | <table> | ||
<tr class="v-firstrow"><th>❑ [[Nitrate]] </th><th>❑ [[Diuretics]]</th><th>❑ [[Antiarrhythmic]] </th></tr> | <tr class="v-firstrow"><th>❑ [[Nitrate]] </th><th>❑ [[Diuretics]]</th><th>❑ [[Antiarrhythmic]] </th></tr> | ||
Line 69: | Line 69: | ||
<tr><td>❑ [[Hydralazine]] </td><td> [[Ethanol]]</td><td>[[Benzodiazepines]] </td></tr> | <tr><td>❑ [[Hydralazine]] </td><td> [[Ethanol]]</td><td>[[Benzodiazepines]] </td></tr> | ||
<tr><td>❑ [[Antipsychotics]] </td><td> ❑ [[Tricyclic antidepressants]] </td><td>❑ [[Barbiturates]] </td></tr> | <tr><td>❑ [[Antipsychotics]] </td><td> ❑ [[Tricyclic antidepressants]] </td><td>❑ [[Barbiturates]] </td></tr> | ||
</table></div> }} | </table> | ||
----- | |||
'''Inquire about the past medical history:'''<br> | |||
❑ Previously healthy <br> | |||
❑ Previous syncope episodes <br> | |||
❑ Cardiovascular disease <br> | |||
❑ Neurological diseases | |||
</div> }} | |||
{{familytree | | | | | | |!| | | | | | | | }} | |||
{{familytree | | | | | | B01 | | | | | | | B01=<div style="float: left; text-align: left; width: 30em; padding:1em;">'''Identify possible triggers:'''<br> | |||
</div>}} | |||
{{familytree | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | Z01 | | | | | | | | Z01= <div style="float: left; text-align: left; width: 30em; padding:1em;">'''Examine the patient:'''<br> | {{familytree | | | | | | Z01 | | | | | | | | Z01= <div style="float: left; text-align: left; width: 30em; padding:1em;">'''Examine the patient:'''<br> |
Revision as of 23:55, 2 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]; Alejandro Lemor, M.D. [3]
Definition
Syncope is the transient loss of consciousness due to cerebral hypoperfusion and it is characterized by a rapid onset, a short duration and a spontaneous complete recovery.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Syncope in the Context of Transient LOC
❑ Determine if there is LOC | |||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||
Characterize the syncope: ❑ Rapid onset, AND ❑ Short duration, AND ❑ Spontaneous complete recovery | |||||||||||||||||||||||||||||||||||
No to ≥ 1: (exclude the following before proceeding with syncope evaluation) ❑ Coma ❑ Aborted SCD ❑ Epilepsy
❑ Metabolic disorders:
❑ Vertebrobasilar TIA | Yes: ❑ Transient LOC | ||||||||||||||||||||||||||||||||||
Non traumatic | Traumatic | ||||||||||||||||||||||||||||||||||
Syncope | Seizure | Psychogenic | |||||||||||||||||||||||||||||||||
Diagnostic and Treatment Flowchart in Patients with Suspected Syncope
Characterize symptoms ❑ Loss of consciousness (LOC)
❑ Prodrome (diaphoresis, nausea, blurry vision)
Inquire about medications intake:
Inquire about the past medical history: | |||||||||||||||||||||||||||||||||||||||||
Identify possible triggers: | |||||||||||||||||||||||||||||||||||||||||
Examine the patient:
| |||||||||||||||||||||||||||||||||||||||||
❑ Absence of heart disease ❑ History of recurrent syncope ❑ After unpleasant sight or smell ❑ Associated to nausea ❑ Head rotation or pressure to carotid sinsus | ❑ After standing up or prolonged standing ❑ Start of new vasodepresive drug ❑ Presence of autonomic neuropathy ❑ Fall in systolic BP ≥ 20 mmHg and/or in diastolic BP of at least≥ 10 mmHg between the supine and sitting BP reading. | ❑ Presence of structural hearth disease ❑ During exertion ❑ Palpitations prior to LOC ❑ Abnormal EKG findings:
| |||||||||||||||||||||||||||||||||||||||
Reflex | Orthostatic hypotension | Cardiovascular | |||||||||||||||||||||||||||||||||||||||
Treatment ❑ Explain diagnosis, provide reassurance ❑ Explain risk of recurrence and avoidance of triggers ❑ Isometric PCM in patients with prodrome | Treatment ❑ Adequate hydration and salt intake ❑ Midodrine or fludrocortisone as adjunctive therapy if needed | Treatment (depends on the cause of the arrhythmia):
| |||||||||||||||||||||||||||||||||||||||
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]
Do's
- Tilt testing is indicated when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient.
- Tilt testing should be considered to discriminate between reflex and OH syncope.
- Perform tilt testing if psychiatric disease.
- Tilt testing may be considered for differentiating syncope with jerking movements from epilepsy.
- If syncope happened after standing up position, there should be documentation with active standing or tilt testing in order to diagnose OH.
- Perform CSM if patient >40 years with syncope of unknown aetiology after initial evaluation.
- If multiple unexplained falls; perform tilt testing.
- Consider ILR before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic syncopal episodes.
- Evaluate neurologically if syncope is due to ANF, to evaluate underlying disease.
Don'ts
- Don't perform carotid sinus massage (CSM) in patients with previous TIA or stroke within the past 3 months and in patients with carotid sinus bruits (except if carotid sinus Doppler studies excluded significant stenosis.
- Don't use tilt testing for assessment of treatment.
- Don't perform isoproterenol tilt testing in patients with ischaemic heart disease.
- Don't use ATP test as a diagnostic test to select patients for cardiac pacing, owing to lack of correlation with spontaneous syncope,.
- Don't perform EPS if there is already indication for ICD in patients with ischemic heart with suspected arrhythmic cause.
- Don't perform EPS in patients with normal ECK, no heart disease, and no palpitations.
References
- ↑ Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). "Recognizing life-threatening causes of syncope". Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter
|month=
ignored (help) - ↑ Kapoor, WN. (2000). "Syncope". N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter
|month=
ignored (help) - ↑ Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009)". Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422 Check
|pmid=
value (help).